Evidence map›Paper›PMID 23664117›Full record

ArticleAmerican journal of human genetics2013

Mutations in B3GALT6, which encodes a glycosaminoglycan linker region enzyme, cause a spectrum of skeletal and connective tissue disorders.

Masahiro Nakajima, Shuji Mizumoto, Noriko Miyake, Ryo Kogawa, Aritoshi Iida, Hironori Ito, Hiroshi Kitoh, Aya Hirayama, Hiroshi Mitsubuchi, Osamu Miyazaki and 21 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 2 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 2 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 15 institutions in 6 countries.

Masahiro NakajimaLaboratory for Bone and Joint Diseases, Center for Integrative Medical Sciences, RIKEN, Tokyo 108-8639, Japan.
Shuji Mizumoto
Noriko Miyake
Ryo Kogawa
Aritoshi Iida
Hironori Ito
Hiroshi Kitoh
Aya Hirayama
Hiroshi Mitsubuchi
Osamu Miyazaki
Rika Kosaki
Reiko Horikawa
Angeline Lai
Roberto Mendoza-Londono
Lucie Dupuis
David Chitayat
Andrew Howard
Gabriela F Leal
Denise Cavalcanti
Yoshinori Tsurusaki
Hirotomo Saitsu
Shigehiko Watanabe
Ekkehart Lausch
Sheila Unger
Luisa Bonafé
Hirofumi Ohashi
Andrea Superti-Furga
Naomichi Matsumoto
Kazuyuki Sugahara
Gen Nishimura
Shiro Ikegawa
University of Toronto · CAYokohama City University · JPHokkaido University · JPNational Center For Child Health and Development · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Lausanne · CHSaitama Children's Medical Center · JPAichi Developmental Disability Center · JPInstituto de Medicina Integral Professor Fernando Figueira · BRKK Women's and Children's Hospital · SGKumamoto University Hospital · JPNagoya University Hospital · JPTokyo Metropolitan Children's Medical Center · JPUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteoglycans (PGs) are a major component of the extracellular matrix in many tissues and function as structural and regulatory molecules. PGs are composed of core proteins and glycosaminoglycan (GAG) side chains. The biosynthesis of GAGs starts with the linker region that consists of four sugar residues and is followed by repeating disaccharide units. By exome sequencing, we found that B3GALT6 encoding an enzyme involved in the biosynthesis of the GAG linker region is responsible for a severe skeletal dysplasia, spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1). B3GALT6 loss-of-function mutations were found in individuals with SEMD-JL1 from seven families. In a subsequent candidate gene study based on the phenotypic similarity, we found that B3GALT6 is also responsible for a connective tissue disease, Ehlers-Danlos syndrome (progeroid form). Recessive loss-of-function mutations in B3GALT6 result in a spectrum of disorders affecting a broad range of skeletal and connective tissues characterized by lax skin, muscle hypotonia, joint dislocation, and spinal deformity. The pleiotropic phenotypes of the disorders indicate that B3GALT6 plays a critical role in a wide range of biological processes in various tissues, including skin, bone, cartilage, tendon, and ligament.

Indexed as

Mutation, MissenseAbnormalities, MultipleAdultChildChild, PreschoolFemaleGalactosyltransferasesGenetic Association StudiesGlycosaminoglycansHigh-Throughput Nucleotide SequencingHumansJoint InstabilityMaleOsteochondrodysplasiasSequence Analysis, DNAB3GALT6 protein, humanGalactosyltransferasesGlycosaminoglycans

Identifiers

PMID23664117
PMCPMC3675233
OpenAlexW1987054961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.